Tsume, Y. Et Al. 2014. The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: Enhanced membrane permeability and enzymatic stability. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.86, no.3 , 514-523.

Tsume, Y., İNCEÇAYIR, T., Song, X., Hilfinger, J. M., & Amidon, G. L., (2014). The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: Enhanced membrane permeability and enzymatic stability. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.86, no.3, 514-523.

Tsume, Yasuhiro Et Al. "The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: Enhanced membrane permeability and enzymatic stability," EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.86, no.3, 514-523, 2014

Tsume, Yasuhiro Et Al. "The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: Enhanced membrane permeability and enzymatic stability." EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.86, no.3, pp.514-523, 2014

Tsume, Y. Et Al. (2014) . "The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: Enhanced membrane permeability and enzymatic stability." EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol.86, no.3, pp.514-523.

@article{article, author={Yasuhiro Tsume Et Al. }, title={The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: Enhanced membrane permeability and enzymatic stability}, journal={EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS}, year=2014, pages={514-523} }